Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Ovarian Neoplasms 1 Neoplasms, Squamous Cell 1 Esophageal Neoplasms 1 Desmoid Tumors 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

nirogacestat 5 Specimen Handling 3 Cryosurgery 3 X-Rays 2 Phantoms, Imaging 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Blood Specimen Collection 2 trifluridine tipiracil drug combination 1 Oxaliplatin 1 Leucovorin 1 Ipilimumab 1 Imatinib Mesylate 1 High-Intensity Focused Ultrasound Ablation 1 Fluorouracil 1 Embolization, Therapeutic 1 Electrochemotherapy 1 E-7386 1 Doxorubicin 1 Cyclophosphamide 1 Cryotherapy 1 CTLA-4 Antigen 1 Bone Density 1 Bleomycin 1 Biopsy 1 Bevacizumab 1 Absorptiometry, Photon 1 4-hydroxy-N-desmethyltamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Desmoid Tumors × High-Intensity Focused Ultrasound Ablation × 1 year × Clear all

NCT05111964 2026-02-04

SarcAblate

Oxford University Hospitals NHS Trust

Phase NA Recruiting

Sarcoma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡